Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Yersinia pestis V Antigen Monoclonal Antibody

Cat. No.VD11Y573

Product TypeVeterinary Antibodies

Size

Product Overview

BioVenic mouse anti-Yersinia pestis V antigen monoclonal antibody can be used in ELISA and WB to help researchers detect or develop diagnosis assays of Yersinia pestis infection.

Specifications

Application WB; ELISA
Clonality Monoclonal Antibody
Classification Primary Antibody
Clone N29Y5
Host Mouse
Target Species Bacteria
Species Reactivity Bacteria
Specificity Yersinia pestis V Antigen
Isotype IgG1
Immunogen Recombinant Yersinia pestis V antigen.
Purification Protein G purified
Conjugation Unconjugated
Preservative and Stabilizer 0.1% Sodium azide (NaN3)
Buffer 1X Phosphate buffered saline, pH 7.4
Physical State Liquid

Target Information

Yersinia pestis V antigen plays a crucial role in the pathogenicity of Yersinia pestis, the bacterium responsible for causing bubonic, septicemic, and pneumonic plague. Yersinia pestis V antigen is a critical virulence factor that not only influences the dynamics of plague in sensitive animal populations but also serves as a valuable target for the development of diagnostic tools, aiding in the timely identification and management of this severe infectious disease.

Target Yersinia pestis V Antigen
Target Synonym Virulence-associated V antigen; Low calcium response locus protein V
Gene ID 66841117
UniProt ID P23994

Shipping and Storage

This product is shipped with dry ice. Store at 4°C on receipt (up to 12 months). DO NOT FREEZE.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Tao, Pan, et al. "Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines." PLoS pathogens 9.7 (2013): e1003495.
Inquiry Basket